Scientific sessions set for Nov. 22
The WVU Cancer Institute (WVUCI) is sponsoring the second Annual WVUCI Scientific Meeting on Nov. 22, 2019, at the Erickson Alumni Center. This is a half-day event with scientific sessions that include outside speakers, as well as reports from selected WVUCI faculty members highlighting their basic, clinical and population research.
The meeting is open to all WVU and NIOSH faculty, employees, students and trainees with an interest in cancer research and cancer care. The outside speakers this year are: Jaime Studts, Ph.D., an expert in behavioral and community-based research; and Elizabeth Sharlow, Ph.D., who focuses on exploiting chemical biology approaches to understanding critical signaling pathways in tumor cell viability.
At 4 p.m., Dr. Otis Brawley will give the Hardesty Lecture on “Cancer Control in the 21st Century” in the Grand Hall of the Erickson Alumni Center. Dr. Brawley is the Bloomberg Distinguished Professor at Johns Hopkins University. Dr. Brawley is a global leader in cancer research and health disparities and a leading voice in training the next generation of scientists and physicians.
We do ask that you RSVP for the event.
In addition, an important part of the meeting will be a trainee poster session designed to highlight all types of cancer research conducted at WVU. The poster session held between 11:30 a.m. - 12:30 p.m. in Salon C of the Erickson Alumni Center. Trainees from across all HSC Schools, Departments, graduate programs and laboratories are invited to present their work at this session. Posters will be competitively judged, with monetary prizes awarded to winners in three categories- Clinical, Population Sciences, and Laboratory-based Research.
Registration is open for the poster session. The registration deadline is 5 p.m. Nov. 18, 2019. (Additional information will be provided to participants following the close of registration.)
Agenda for Meeting: http://www2.hsc.wvu.edu/mbrcc/newsletter/pdfs/AnnualMeeting2019.pdf
Submit Poster: https://www.surveymonkey.com/r/6JW2CVB
Register for Scientific Meeting: https://wvu.qualtrics.com/jfe/form/SV_cJeRRJTA6YDYMTP
Dr. Hannah Hazard-Jenkins, right, examines a patient at WVU’s Mary Babb Randolph Cancer Center. Hazard-Jenkins is an advocate for the Norma Mae Huggins Cancer Research Endowment Fund, which provides support for clinical research trials at the WVU Cancer Institute. (WVU Photo)
Submissions sought for Robert E. Stitzel Award for Student-Generated Educational Media in Pharmacology
The Stitzel Award Competition is soliciting submissions of pharmacology educational media from students in any health professional or graduate program within the WVU Health Sciences Center.
The WVU Cancer Institute has enrolled two of the first three patients in a national clinical trial for a novel breast cancer vaccine.